These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 29600044)
21. Screening and verification of hub genes in esophageal squamous cell carcinoma by integrated analysis. Wu H; Zhu P; Shu P; Zhang S Sci Rep; 2024 Mar; 14(1):6894. PubMed ID: 38519533 [TBL] [Abstract][Full Text] [Related]
22. Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC). Wang J; Yu P; Luo J; Sun Z; Yu J; Wang J Front Pharmacol; 2021; 12():626972. PubMed ID: 33935718 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Wang F; Zhang L; Xu Y; Xie Y; Li S Front Cell Dev Biol; 2021; 9():676156. PubMed ID: 34124063 [No Abstract] [Full Text] [Related]
24. Identification of four genes and biological characteristics of esophageal squamous cell carcinoma by integrated bioinformatics analysis. Song Y; Wang X; Wang F; Peng X; Li P; Liu S; Zhang D Cancer Cell Int; 2021 Feb; 21(1):123. PubMed ID: 33602210 [TBL] [Abstract][Full Text] [Related]
25. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis. Zou Z; Gan S; Liu S; Li R; Huang J Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570 [TBL] [Abstract][Full Text] [Related]
26. Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy. Yang W; Zhao X; Han Y; Duan L; Lu X; Wang X; Zhang Y; Zhou W; Liu J; Zhang H; Zhao Q; Hong L; Fan D Cancer Cell Int; 2019; 19():142. PubMed ID: 31139019 [TBL] [Abstract][Full Text] [Related]
27. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma. Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619 [TBL] [Abstract][Full Text] [Related]
28. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
29. Knockdown of RAD51AP1 suppressed cell proliferation and invasion in esophageal squamous cell carcinoma. Hu YY; Ma CC; Ai KX Discov Oncol; 2022 Oct; 13(1):101. PubMed ID: 36197550 [TBL] [Abstract][Full Text] [Related]
30. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma. Chen J; Qian Z; Li F; Li J; Lu Y Gut Liver; 2017 Jan; 11(1):112-120. PubMed ID: 27458175 [TBL] [Abstract][Full Text] [Related]
31. Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network. Shen Y; Tantai J; Zhao H Eur J Med Res; 2014 Oct; 19(1):52. PubMed ID: 25358439 [TBL] [Abstract][Full Text] [Related]
32. Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis. Wang X; Li G; Luo Q; Gan C Oncol Lett; 2018 Jun; 15(6):8983-8990. PubMed ID: 29844815 [TBL] [Abstract][Full Text] [Related]
33. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray. Xie W; Ji L; Zhao T; Gao P Med Sci Monit; 2015 May; 21():1333-44. PubMed ID: 25957414 [TBL] [Abstract][Full Text] [Related]
34. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
35. Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database. Tian F; Zhao J; Fan X; Kang Z J Thorac Dis; 2017 Jan; 9(1):42-53. PubMed ID: 28203405 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma. Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927 [TBL] [Abstract][Full Text] [Related]
37. Identification of pathogenic genes and upstream regulators in age-related macular degeneration. Zhao B; Wang M; Xu J; Li M; Yu Y BMC Ophthalmol; 2017 Jun; 17(1):102. PubMed ID: 28651595 [TBL] [Abstract][Full Text] [Related]
38. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma. Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599 [No Abstract] [Full Text] [Related]
39. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Li X; Xiao X; Chang R; Zhang C J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]